IGF-1 and leptin associate with fetal HDL cholesterol at birth: Examination in offspring of mothers with type 1 diabetes

Diabetes

Volumn 56, Issue 11, 2007, Pages 2705-2709

  Nelson, Scott M ^a   Freeman, Dilys J ^a   Sattar, Naveed ^b   Johnstone, Frank D ^c   Lindsay, Robert S ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIRTH; BIRTH WEIGHT; CESAREAN SECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INFANT; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGENY;

ADULT; BIRTH WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 1; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LIPOPROTEINS; MALE; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS; REFERENCE VALUES;

EID: 35748963855     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db07-0585     Document Type: Article

References (25)

1. Merzouk H, Meghelli-Bouchenak M, el-Korso N, Belleville J, Prost J: Low birth weight at term impairs cord serum lipoprotein compositions and concentrations. Eur J Pediatr 157:321-326, 1998
2. Jones JN, Gercel-Taylor C, Taylor DD: Altered cord serum lipid levels associated with small for gestational age infants. Obstet Gynecol 93:527-531, 1999
3. Roberts A, Nava S, Bocconi L, Salmona S, Nicolini U: Liver function tests and glucose and lipid metabolism in growth-restricted fetuses. Obstet Gynecol 94:290-294, 1999
4. Ophir E, Oettinger M, Nisimov J, Hirsch Y, Fait V, Dourleshter G, Shnaider O, Snitkovsky T, Bornstein J: Cord blood lipids concentrations and their relation to body size at birth: possible link between intrauterine life and adult diseases. Am J Perinatol 21:35-40, 2004
5. Barker DJ: The developmental origins of adult disease. J Am Coll Nutr 23:588S-595S, 2004
6. Woollett LA: Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr 82:1155-1161, 2005
7. Varastehpour A, Radaelli T, Minium J, Ortega H, Herrera E, Catalano P, Hauguel-de Mouzon S: Activation of phospholipase A2 is associated with generation of placental lipid signals and fetal obesity. J Clin Endocrinol Metab 91:248-255, 2006
8. Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL: Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 89:4607-4614, 2004
9. Lindsay RS, Hamilton BA, Calder AA, Johnstone FD, Walker JD: The relation of insulin, leptin and IGF-1 to birthweight in offspring of women with type 1 diabetes. Clin Endocrinol (Oxf) 61:353-359, 2004
10. Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, Bennett PH, Knowler WC: Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49:2208-2211, 2000
11. Manderson JG, Mullan B, Patterson CC, Hadden DR, Traub AI, McCance DR: Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia 45:991-996, 2002
12. Lindsay RS, Walker JD, Havel PJ, Hamilton BA, Calder AA, Johnstone FD: Adiponectin is present in cord blood but is unrelated to birth weight. Diabetes Care 26:2244-2249, 2003
13. Lindsay RS, Walker JD, Halsall I, Hales CN, Calder AA, Hamilton BA, Johnstone FD: Insulin and insulin propeptides at birth in offspring of diabetic mothers. J Clin Endocrinol Metab 88:1664-1671, 2003
14. Valle M, Martos R, Gascon F, Canete R, Zafra MA, Morales R: Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 31:55-62, 2005
15. Gil-Campos M, Canete R, Gil A: Hormones regulating lipid metabolism and plasma lipids in childhood obesity. Int J Obes Relat Metab Disord 28 (Suppl. 3):S75-S80, 2004
16. Ong K, Kratzsch J, Kiess W, Dunger D: Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab 87:1041-1044, 2002
17. Ceda GP, Dall'Aglio E, Magnacavallo A, Vargas N, Fontana V, Maggio M, Valenti G, Lee PD, Hintz RL, Hoffman AR: The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab 83:499-502, 1998
18. Wolfrum C, Poy MN, Stoffel M: Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11:418-422, 2005
19. Luo G, Hurtig M, Zhang X, Nilsson-Ehle P, Xu N: Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells. Biochim Biophys Acta 1734:198-202, 2005
20. Xu N, Ahren B, Jiang J, Nilsson-Ehle P: Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells. Biochim Biophys Acta 1761:256-260, 2006
21. Kilby MD, Neary RH, Mackness MI, Durrington PN: Fetal and maternal lipoprotein metabolism in human pregnancy complicated by type I diabetes mellitus. J Clin Endocrinol Metab 83:1736-1741, 1998
22. Hiden U, Maier A, Bilban M, Ghaffari-Tabrizi N, Wadsack C, Lang I, Dohr G, Desoye G: Insulin control of placental gene expression shifts from mother to foetus over the course of pregnancy. Diabetologia 49:123-131, 2006
23. Riemens SC, van Tol A, Sluiter WJ, Dullaart RP: Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes 48:1631-1637, 1999
24. Riemens SC, Dullaart RP: Twenty-four hours of insulin infusion does not lower plasma lipoprotein(a) in healthy men. Scand J Clin Lab Invest 60:119-123, 2000
25. Dullaart RP, van Tol A: Twenty four hour insulin infusion impairs the ability of plasma from healthy subjects and type 2 diabetic patients to promote cellular cholesterol efflux. Atherosclerosis 157:49-56, 2001